Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | Radiology Imaging | November 16, 2015

Imaging’s Evolution Fulfills Patient-centric Destiny

Imaging’s Evolution Fulfills Patient-centric Destiny

Photo Courtesy of Philips Healthcare

The 1990s were cast by myth and ambition. Taxi drivers wearing caps hyping digital radiography (DR); banners atop RSNA booths announcing the arrival of flat panel detectors; demos of digital radiographs being fed into picture archiving and communication systems (PACS).

But digital radiography was not embraced in those early years. The first detectors were difficult to fabricate, expensive to buy and available only in small sizes. Chest DR? Not for a while. And when large panels did appear, they were fragile, which is why DR took so long to become part of mobile X-ray.

Those days are all but forgotten now, lost in a tightly punctuated timeline leading to the present. In a few weeks, at McCormick Place in Chicago, Konica will show wireless panels that can withstand patients weighing up to 660 pounds. Carestream will present third-generation DRX Plus panels that can be submerged under a meter of water for 30 minutes without failure — so much for exposing flat panels to body fluids. As if anyone remembers them.

Since entering the market in 1998, Canon has sold 30,000 DR detectors. Thirty thousand! And that’s just Canon.

To say digital X-ray is indispensible today is an understatement. It saves time, improving patient management; increases image quality, which boosts diagnostic confidence, if not accuracy itself. Digitally controlled automatic exposure and image processing software all but eliminate the need for repeat exposures. Dose optimization spares patients unnecessary radiation exposure.

What makes all this so astounding is that today these facts are blasé, taken for granted, as if they were always true … as if DR were always so capable. It was not, no more than magnetic resonance (MR) and computed tomography (CT) burst into medicine guns blazing with clinical relevance.

At its inception, MR displayed anatomy with crystal clarity but little else. With the possible exception of multiple sclerosis’ characteristic “string of pearls” first seen on MR images in the 1980s and tied to demyelination documented in animal research decades earlier, MRI was diagnostically unproven. CT’s first brain image, cast in 1971 on an 80 x 80-pixel matrix that took two and a half hours to process, looked like a bowl of oatmeal.

Ultrasound? An early prototype repurposed the gun turret of a surplus B-29 into a water bath. The patient sat in it, a lead weight tied around his abdomen to prevent floating, while a transducer circled. In 1946 nuclear medicine came after, not before therapy, the filmed depiction of an atomic cocktail given to treat a patient with thyroid cancer. In the years that followed, nuclear became an anagram for “unclear.”

Yet each modality persevered until today radiology is digital from CT and MR to ultrasound and X-ray, and, most recently, even to nuclear medicine. And patients are better off for it. As time goes on, they will be more so.

Radiology continues to reinvent itself, evolving with the introduction of new digital technologies implanted in its DNA like nucleic snippets conferring new traits to genetically modified foods.

Spectral CT from GE and Philips, and Siemens’ dual-energy CT, deliver information about the chemical composition of body tissues, structures and contrast media by leveraging quantitative analyses of X-rays at different energies. From super premium CTs to entry level products at RSNA 2015, all will feature low-dose scanning, the ultimate expression of imaging’s concern for patients. Niche products will show how specialty applications can reshape scanner design: orthopedics’ effect on a work-in-progress CT in the Carestream booth; women’s health on an FDA-approved breast CT at Koning.

Altogether free from ionizing radiation, MRI has morphed into wide-bore configurations that have carried on the mission of open MR, offering relief to patients fearful of tight spaces without compromising scans. Patient comfort exerts its influence through Toshiba’s Pianissimo, which damps noise, and GE’s Silent Scan, which can all but eliminate it.

Ultrasound has become smaller, lighter, easier to operate, eminently programmable and exquisitely adapted to patient needs. On the exhibit floor, Philips will showcase Lumify, a smartphone app with USB-pluggable transducers.  Three years have passed already since Siemens launched its Freestyle, featuring wireless transducers that markedly decrease the risk of infection, when used at point-of-care.

The steak-and-potatoes hybrid of positron emission tomography (PET) and CT, which galvanized oncology at the turn of the millennium, may cede its position in some instances to a steak-and-broccoli combo of PET and MR that promises to deliver similar clinical results without the ionizing radiation of CT.

Today physicians and administrators are perched on a transition from volume to value medicine. And radiology couldn’t be in a better position. Digital innovations have made radiology patient-centric.

Editor’s note: This is the second blog in a series of four by industry consultant Greg Freiherr on The Evolution of Radiology. You can view the first blog in this series, "Radiology Faces Frightening New World," here.

 

Related Content

Ceiling-mounted X-ray system includes MyExam Companion intelligent user interface to guide technologist through exam workflow
News | X-Ray | October 26, 2020
October 26, 2020 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S.
An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

Feature | CT Angiography (CTA) | October 23, 2020
October 22, 2020 – In the FORECAST randomized clinical trial, the use of ...
This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large

This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large-scale analyses of data combined across multiple research sites, the ENIGMA Brain Injury will develop and test methods and procedures for making sense of the complexity in this data. Images courtesy of Olsen et al., Brain Imaging and Behavior, 2020

News | Magnetic Resonance Imaging (MRI) | October 23, 2020
October 23, 2020 — Trau...
A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe.

A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | October 22, 2020
October 22, 2020 — According to an open-...
The fMRI hyperscanning environment.

(A) The fMRI hyperscanning environment. The clinician (1) and patient (2) were positioned in two different 3T MRI scanners. An audio-video link enabled online communication between the two scanners (3), and video images were used to extract frame-by-frame facial expression metrics. During simultaneous acquisition of blood oxygen level–dependent (BOLD)–fMRI data, the clinician used a button box (4) to apply electroacupuncture (EA) treatment (real/sham, double-blind) to the patient (5) to alleviate evoked pressure pain to the leg (6; Hokanson cuff inflation). Pain and affect related to the treatment were rated after each trial. (B) Study overview. After an initial behavioral visit, each individual participated in a Clinical-Interaction (hyperscan preceded by a clinical intake) and No-Interaction condition (hyperscan without a preceding intake), in a counterbalanced order, with two different partners. (C) Experimental protocol. Each hyperscan was composed of 12 repeated trials (four verum EA, four sham EA, and four no treatment) in a pseudo-randomized order. After a resting period (far left), both participants were shown a visual cue to indicate whether the next pain stimulus would be treated (green frame) or not treated (red frame) by the clinician. These cues prompted clinicians prepare to either apply or not apply treatment while evoking corresponding anticipation for the patient. Following the anticipation cue, moderately painful pressure pain was applied to the patient’s left leg, while the clinician applied or did not apply treatment, respectively. After another resting period, participants rated pain (patients), vicarious pain (clinicians), and affect (both) using a visual analog scale (VAS).

News | Clinical Trials | October 22, 2020
October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | October 21, 2020
October 21, 2020 — According to an artic...
According to an inquest, a man with a heart disorder and chest pain died two days after a doctor viewed the wrong scan and sent him home
News | Computed Tomography (CT) | October 21, 2020
October 21, 2020 — The BBC News
Flowchart of patient inclusion and exclusion.

Figure 1. Flowchart of patient inclusion and exclusion.

News | Coronavirus (COVID-19) | October 20, 2020
October 20, 2020 — A new multi-institutional study published in the journal ...
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT) | October 20, 2020
October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnos